Cited by 131T-cell and Retrovirus StudiesHIV Research and TreatmentViral-associated cancers and disorders

Infection of peripheral blood mononuclear cells and cell lines by cell-free human T-cell lymphoma/leukemia virus type I

Open access
Fan, N, Gavalchin, J, Paul, B, Wells, K H, Lane, M J, Poiesz, B J·1992·Journal of Clinical Microbiology

Abstract

Previous studies of in vitro infection by human T-cell lymphoma/leukemia virus type I (HTLV-I) have required cocultivation of target cells with HTLV-I cell lines or vesicular stomatitis virus pseudotypes containing HTLV-I envelope proteins. We report here the development of a cell-free infection assay for HTLV-I. Target cells were incubated with purified, DNase-treated HTLV-I virions for 4 h at 37 degrees C. Target cell DNA was then analyzed for the presence of newly synthesized HTLV-I proviral DNA by the highly sensitive polymerase chain reaction. Using this assay system, we have been able to consistently detect in vitro infection of a variety of cellular targets by different HTLV-I isolates. Optimal infection required the presence of 10 micrograms of DEAE-dextran per ml. The assay was dose dependent with respect to virus input. In general, the amount of proviral DNA detected correlated with the level of HTLV-I receptors present on the surface of the target cells, as measured by fluorochrome-labelled HTLV-I binding. Finally, the specificity of the assay was confirmed by demonstrating that the cell line, L1q, a somatic cell hybrid containing human chromosome 17q, to which the gene for the HTLV-I receptor has been mapped, was susceptible to infection by HTLV-I, while the parental mouse cell line from which it was derived, LMTK-, which lacks human chromosome 17q, was not.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1128/jcm.30.4.905-910.1992

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • HTLV-1-infected T cells produce very few free virions in vitro, of which only 1 out of 10^5-10^6 is infectious.

    “HTLV-1-infected T cells have been shown to produce very few free virions in vitro, of which only 1 out of 105–106 is infectious [20,21].”

    From HIV-1 and HTLV-1 Transmission Modes: Mechanisms and Importance for Virus Spread (2022) · cites this paper as [21]

    In the “Effects of DEAE-dextran” section (page not available), the paper estimates roughly one infectious particle per 10^6 HTLV-I virions in its cell-free infection assay, supporting the infectivity figure. The Methods describe obtaining virions from infected cell cultures, but do not establish that infected T cells produce very few free virions in vitro. (LLM, conf=0.87)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. 12a.Lane, M. J., et al. Chromosoma, in press.

Cited by

Sorted by citations

Authors
Fan, N., Gavalchin, J., Paul, B., Wells, K. H., Lane, M. J., & Poiesz, B. J.
Affiliations
SUNY Upstate Medical University (US)
Venue
Journal of Clinical Microbiology
Published
1992-04
Volume
30
Issue
4
Pages
905-910
ISSN
  • 0095-1137 (ISSN-L)
  • 1098-660X
OpenAlex
W1843784436
Cited by
131
References
32
Citations by year
2026: 1 · 2025: 2 · 2024: 1 · 2023: 3 · 2022: 6 · 2021: 3 · 2020: 3 · 2019: 4 · 2018: 2 · 2017: 4 · 2016: 4 · 2015: 1 · 2014: 5 · 2013: 1 · 2012: 4
FWCI
2.58
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Microbiology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (5r01hg000318-03, 5r01hl043602-03)
  • National Heart, Lung, and Blood Institute (R01 HL-43602-01)
  • National Human Genome Research Institute (HG00318)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and Retrovirus Studies
  • Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
  • Health Sciences › Medicine › Oncology › Viral-associated cancers and disorders
Keywords
HTLV-1, peripheral blood mononuclear cells, HTLV-I proviral DNA, DEAE-dextran, chromosome 17q, HTLV-1 infection
MeSH terms
Adult, Cell Line, DNA, Viral, Humans, Kinetics, Leukocytes, Mononuclear, Proviruses, Viral Proteins, Virology, Human T-lymphotropic virus 1, HTLV-I Infections, Polymerase Chain Reaction, In Vitro Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review